CRTX Stock Price, News & Analysis
Company Description
CRTX (Nasdaq: CRTX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $70.5M.
CRTX stock has declined 96.5% over the past year.
This page provides a comprehensive overview of CRTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CRTX (CRTX) stock. Over the past 12 months, the stock has lost 96.5%. At a market capitalization of $70.5M, CRTX is classified as a micro-cap stock with approximately 36.2M shares outstanding.
Latest News
CRTX has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, management, acquisition, conferences. View all CRTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CRTX Company Profile & Sector Positioning
CRTX (CRTX) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing CRTX often look at related companies in the same sector, including X4 Pharmaceuticals Inc (XFOR), Adicet Bio Inc (ACET), OS THERAPIES INCORPORATED (OSTX), (HTBX), and Immix Biopharma Inc (IMMX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CRTX's relative position within its industry.